Perspective Therapeutics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Perspective Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $12.29. The average 1-year stock price forecast is 326.74% higher than the current stock price, while the lowest is $5.00 (+73.61%) and the highest is $18 (+525.00%).

Price Target: $12.29 (+326.74%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$12.29	$13	$18
Change	+73.61%	+326.74%	+351.39%	+525.00%

Analyst Ratings

The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	12	12	12	12	12	12
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andy Hsieh William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Sep 18, 2026
David Lebowitz BMO Capital	BMO Capital	Buy Maintains $11	Buy	Maintains	$11	+281.94%	Sep 15, 2026
Unknown Analyst Wedbush No rating	Wedbush	Buy Maintains $11	Buy	Maintains	$11	+281.94%	Sep 15, 2026
Gregory Renza Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Sep 15, 2026
Justin Walsh JonesTrading	JonesTrading	Buy Reiterates $18	Buy	Reiterates	$18	+525.00%	Aug 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

320.07K

from 884.00K

-63.79%

from 884.00K

Revenue Next Year

396.18K

from 320.07K

23.78%

from 320.07K

EPS This Year

-0.98

from -1.40

EPS Next Year

-1.01

from -0.98

Fiscal Year	FY 2022	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2022	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	5.42M	1.43M	1.45M	884.00K	320.07K
Revenue Growth	-	-	-73.52%	1.40%	-39.20%	-63.79%
Operating Income	-6.42M	-8.80M	-40.94M	-66.80M	-113.56M	-123.46M
Net Income	-7.27M	-10.76M	-46.51M	-79.28M	-103.12M	-114.41M
EPS	-	-	-	-	-1.40	-0.98
Free Cash Flow	-	-	-	-	-95.23M	-111.22M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.0M
Avg	320,070
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	13.1%
Avg	-63.8%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.83
Avg	-0.98
Low	-1.27

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-